Daniel Barber

CIK: 0001742266

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)10 (55.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)5 (27.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AQST

Aquestive Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (18 total)

AQST
Aquestive Therapeutics, Inc.
Oct 15, 2026
Sale(S)
Direct
25K shares at avg. $4.22$106K
AQST
Aquestive Therapeutics, Inc.
Sep 15, 2026
Sale(S)
Direct
25K shares at avg. $4.82$120K
AQST
Aquestive Therapeutics, Inc.
Sep 8, 2026
In-the-Money(X)
Direct
91.7K shares at avg. $0.96$88K
AQST
Aquestive Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Direct
25K shares at avg. $4.29$107K
AQST
Aquestive Therapeutics, Inc.
Jul 16, 2026
Sale(S)
Direct
20.4K shares at avg. $4.00$82K
AQST
Aquestive Therapeutics, Inc.
Jul 15, 2026
Sale(S)
Direct
4.6K shares at avg. $4.03$19K
AQST
Aquestive Therapeutics, Inc.
Jun 15, 2026
Sale(S)
Direct
25K shares at avg. $4.16$104K
AQST
Aquestive Therapeutics, Inc.
May 15, 2026
Sale(S)
Direct
8.3K shares at avg. $4.29$35K
AQST
Aquestive Therapeutics, Inc.
May 5, 2026
Tax Payment(F)
Direct
335.9K shares at avg. $4.18$1.4M
AQST
Aquestive Therapeutics, Inc.
Mar 10, 2026
Sale(S)
Direct
180.7K shares at avg. $4.17$754K
AQST
Aquestive Therapeutics, Inc.
Mar 9, 2026
Award(A)
Direct
262K shares-
AQST
Aquestive Therapeutics, Inc.
Sep 26, 2025
Sale(S)
Direct
91.3K shares at avg. $6.03$551K
AQST
Aquestive Therapeutics, Inc.
Sep 19, 2025
Sale(S)
Direct
400 shares at avg. $6.00$2K
AQST
Aquestive Therapeutics, Inc.
Mar 9, 2025
Tax Payment(F)
Direct
54K shares at avg. $2.65$143K
AQST
Aquestive Therapeutics, Inc.
Mar 7, 2025
Award(A)
Performance Stock Units
Direct
293.1K shares-
AQST
Aquestive Therapeutics, Inc.
Mar 7, 2025
Award(A)
Direct
272K shares-
AQST
Aquestive Therapeutics, Inc.
Mar 7, 2025
Tax Payment(F)
Direct
29.3K shares at avg. $2.65$78K
AQST
Aquestive Therapeutics, Inc.
Mar 9, 2024
Tax Payment(F)
Direct
56.8K shares at avg. $4.88$277K

		Type	Shares	Price		Ownership
Oct 15, 2026	AQST Aquestive Therapeutics, Inc.	Sale(S)	25,000	$4.22	$105,600	Direct
Sep 15, 2026	AQST Aquestive Therapeutics, Inc.	Sale(S)	25,000	$4.82	$120,487	Direct
Sep 8, 2026	AQST Aquestive Therapeutics, Inc.	In-the-Money(X)	91,743	$0.96	$88,073	Direct
Aug 17, 2026	AQST Aquestive Therapeutics, Inc.	Sale(S)	25,000	$4.29	$107,168	Direct
Jul 16, 2026	AQST Aquestive Therapeutics, Inc.	Sale(S)	20,369	$4.00	$81,509	Direct
Jul 15, 2026	AQST Aquestive Therapeutics, Inc.	Sale(S)	4,631	$4.03	$18,683	Direct
Jun 15, 2026	AQST Aquestive Therapeutics, Inc.	Sale(S)	25,000	$4.16	$104,010	Direct
May 15, 2026	AQST Aquestive Therapeutics, Inc.	Sale(S)	8,257	$4.29	$35,413	Direct
May 5, 2026	AQST Aquestive Therapeutics, Inc.	Tax Payment(F)	335,922	$4.18	$1,404,154	Direct
Mar 10, 2026	AQST Aquestive Therapeutics, Inc.	Sale(S)	180,677	$4.17	$753,965	Direct
Mar 9, 2026	AQST Aquestive Therapeutics, Inc.	Award(A)	262,000	-	$0	Direct
Sep 26, 2025	AQST Aquestive Therapeutics, Inc.	Sale(S)	91,343	$6.03	$551,191	Direct
Sep 19, 2025	AQST Aquestive Therapeutics, Inc.	Sale(S)	400	$6.00	$2,400	Direct
Mar 9, 2025	AQST Aquestive Therapeutics, Inc.	Tax Payment(F)	53,998	$2.65	$143,095	Direct
Mar 7, 2025	AQST Aquestive Therapeutics, Inc.	Award(A) Performance Stock Units	293,100	-	-	Direct
Mar 7, 2025	AQST Aquestive Therapeutics, Inc.	Award(A)	272,000	-	-	Direct
Mar 7, 2025	AQST Aquestive Therapeutics, Inc.	Tax Payment(F)	29,307	$2.65	$77,664	Direct
Mar 9, 2024	AQST Aquestive Therapeutics, Inc.	Tax Payment(F)	56,824	$4.88	$277,301	Direct

1-18 of 18 transactions

About Barber Daniel

Barber Daniel (SEC CIK 0001742266) files insider reports with the SEC as President and CEO of Aquestive Therapeutics, Inc. (AQST).

Signal8 holds 14 ownership filings by Barber Daniel, all Form 4s, filed between Oct 2, 2024 and Oct 16, 2026. Those filings report 18 transactions, from Mar 9, 2024 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Barber Daniel's filings is in WARREN, NJ.

Recent filings by Barber Daniel

Oct 15, 2026: Open-market sale of AQST shares (Form 4, code S).
Sep 15, 2026: Open-market sale of AQST shares (Form 4, code S).
Sep 8, 2026: Option exercise of AQST shares (Form 4, code X).
Aug 17, 2026: Open-market sale of AQST shares (Form 4, code S).
Jul 16, 2026: Open-market sale of AQST shares (Form 4, code S).

Other insiders filing for Aquestive Therapeutics, Inc. (AQST)

Cochran John, Director
Daly Richard J, Director
Korczynski Sherry, Chief Commercial Officer
Boyd Peter E., Chief People Officer
Jung Cassie, Chief Operating Officer
Krop Julie, Director

How to read Form 4 transaction codes